These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3147914)

  • 21. Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation.
    Mattila JS; Korsbäck A; Krootila K; Holopainen JM
    Acta Ophthalmol; 2013 Aug; 91(5):e410-1. PubMed ID: 23844860
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effects of anti-OEP-antibodies in the Pseudomonas aeruginosa (Fisher's seven serotypes) infection of mice and the influence of this antibody upon the phagocytic activity of mice spleen macrophages (author's transl)].
    Haranaka K; Satomi N; Matsuo M; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Apr; 53(4):175-81. PubMed ID: 89175
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of Sanoserum P.A. in the treatment of Pseudomonas aeruginosa infection].
    Philips R; Philips I
    Klin Oczna; 1987 Apr; 89(4):158-9. PubMed ID: 3118093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
    Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
    Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 28. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies.
    Schreiber JR; Nixon KL; Tosi MF; Pier GB; Patawaran MB
    J Immunol; 1991 Jan; 146(1):188-93. PubMed ID: 1898598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15(1):56-9. PubMed ID: 3106230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas immunoglobulin and vaccine in burn patients.
    Bose B
    Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.
    François B; Luyt CE; Dugard A; Wolff M; Diehl JL; Jaber S; Forel JM; Garot D; Kipnis E; Mebazaa A; Misset B; Andremont A; Ploy MC; Jacobs A; Yarranton G; Pearce T; Fagon JY; Chastre J
    Crit Care Med; 2012 Aug; 40(8):2320-6. PubMed ID: 22622405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas immunoglobulin therapy in patients with Pseudomonas sepsis and septic shock.
    Pilz G; Class I; Boekstegers P; Pfeifer A; Müller U; Werdan K
    Antibiot Chemother (1971); 1991; 44():120-35. PubMed ID: 1801630
    [No Abstract]   [Full Text] [Related]  

  • 35. [The concomitant effect of a gamma-globulin preparation with an antibiotic on experimental Pseudomonas aeruginosa infections in mice].
    Shigeno Y; Sawatari K; Watanabe K; Tanaka H; Tomonaga A; Kohno S; Suzuyama Y; Yamaguchi K; Saito A; Hara K
    Kansenshogaku Zasshi; 1983 Jun; 57(6):531-6. PubMed ID: 6443738
    [No Abstract]   [Full Text] [Related]  

  • 36. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
    Secher T; Fauconnier L; Szade A; Rutschi O; Fas SC; Ryffel B; Rudolf MP
    J Antimicrob Chemother; 2011 May; 66(5):1100-9. PubMed ID: 21393169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives.
    Bellanti JA; Zeligs BJ; Kulczycki LL
    Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307
    [No Abstract]   [Full Text] [Related]  

  • 39. [The production and use of plasma against Pseudomonas aeruginosa infection].
    Popov SD; Ryzhkov SV; Stanislavskiĭ ES; Plakhotnikov AIa; Gurevich KIa; Sergienko AI; Zaĭchik VI; Popova NN; Fedorova GM; Edvabnaia LS
    Voen Med Zh; 1990 Dec; (12):30-1. PubMed ID: 2127965
    [No Abstract]   [Full Text] [Related]  

  • 40. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
    Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
    J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.